Biblio
Venetoclax combinations induce high response rates in newly diagnosed Acute Myeloid Leukemia patients ineligible for intensive chemotherapy in routine practice. Am J Hematol. 2021.
Optimal therapeutic strategies for mixed phenotype acute leukemia. Curr Opin Hematol. 2020.
. Leukocyte Adhesion Deficiency -A Multicenter National Experience. Eur J Clin Invest. 2018:e13047.
. .